Inari Medical, Inc.

NasdaqGS:NARI Stok Raporu

Piyasa değeri: US$3.0b

Inari Medical Yönetim

Yönetim kriter kontrolleri 3/4

Inari Medical CEO'su Drew Hykes, Jan2023 tarihinde atandı, in görev süresi 1.83 yıldır. in toplam yıllık tazminatı $ 5.08M olup, şirket hissesi ve opsiyonları dahil olmak üzere 13.8% maaş ve 86.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.65% ine doğrudan sahiptir ve bu hisseler $ 19.28M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.3 yıl ve 5 yıldır.

Anahtar bilgiler

Drew Hykes

İcra Kurulu Başkanı

US$5.1m

Toplam tazminat

CEO maaş yüzdesi13.8%
CEO görev süresi1.8yrs
CEO sahipliği0.7%
Yönetim ortalama görev süresi2.3yrs
Yönetim Kurulu ortalama görev süresi5yrs

Son yönetim güncellemeleri

Recent updates

Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Nov 07
Inari Medical, Inc. (NASDAQ:NARI) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable

Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues

Sep 23
Investors Interested In Inari Medical, Inc.'s (NASDAQ:NARI) Revenues

Inari Medical: A Touch Of Uncertainty And Overvaluation

Jul 05

At US$43.23, Is It Time To Put Inari Medical, Inc. (NASDAQ:NARI) On Your Watch List?

Jun 18
At US$43.23, Is It Time To Put Inari Medical, Inc. (NASDAQ:NARI) On Your Watch List?

Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 26% Higher

May 23
Market Participants Recognise Inari Medical, Inc.'s (NASDAQ:NARI) Revenues Pushing Shares 26% Higher

Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

May 02
Is Inari Medical, Inc. (NASDAQ:NARI) Trading At A 29% Discount?

Inari Medical: Buy On Growing TAM

Mar 27

Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Mar 08
Why We're Not Concerned Yet About Inari Medical, Inc.'s (NASDAQ:NARI) 25% Share Price Plunge

Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

Dec 14
Is Now The Time To Look At Buying Inari Medical, Inc. (NASDAQ:NARI)?

A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Oct 23
A Look At The Fair Value Of Inari Medical, Inc. (NASDAQ:NARI)

Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Sep 18
Inari Medical (NASDAQ:NARI) Is In A Strong Position To Grow Its Business

Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Aug 14
Is Inari Medical, Inc. (NASDAQ:NARI) Potentially Undervalued?

Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

Jul 25
Inari Medical, Inc. (NASDAQ:NARI) Shares Could Be 23% Above Their Intrinsic Value Estimate

We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Jun 18
We Think Inari Medical (NASDAQ:NARI) Can Afford To Drive Business Growth

Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

Apr 17
Inari Medical, Inc.'s (NASDAQ:NARI) Price In Tune With Revenues

CEO Tazminat Analizi

Drew Hykes'un ücretlendirmesi Inari Medical'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Sep 30 2024n/an/a

-US$79m

Jun 30 2024n/an/a

-US$57m

Mar 31 2024n/an/a

-US$24m

Dec 31 2023US$5mUS$700k

-US$2m

Sep 30 2023n/an/a

-US$3m

Jun 30 2023n/an/a

-US$16m

Mar 31 2023n/an/a

-US$28m

Dec 31 2022US$3mUS$500k

-US$29m

Sep 30 2022n/an/a

-US$22m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$758k

Dec 31 2021US$3mUS$450k

US$10m

Sep 30 2021n/an/a

US$16m

Jun 30 2021n/an/a

US$25m

Mar 31 2021n/an/a

US$17m

Dec 31 2020US$829kUS$384k

US$14m

Sep 30 2020n/an/a

US$7m

Jun 30 2020n/an/a

US$1m

Mar 31 2020n/an/a

US$4m

Dec 31 2019US$654kUS$316k

-US$1m

Tazminat ve Piyasa: Drew 'ın toplam tazminatı ($USD 5.08M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 6.60M ).

Tazminat ve Kazançlar: Drew şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Drew Hykes (51 yo)

1.8yrs

Görev süresi

US$5,083,365

Tazminat

Mr. Andrew J. Hykes, also known as Drew, served as Chief Operating Officer at Inari Medical, Inc. since October 2020 until December 2022 and serves as its President and Director since January 2023 and serv...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Andrew Hykes
CEO, President & Director1.8yrsUS$5.08m0.65%
$ 19.3m
Thomas Tu
Chief Medical Officer5.3yrsUS$2.50m0.47%
$ 14.0m
Paul Koehn
Senior Vice President of Operations1.8yrsVeri yokVeri yok
John Hsu
Vice President of Investor Relationsno dataVeri yokVeri yok
Angela Ahmad
General Counsel & Secretary4yrsVeri yokVeri yok
Eric Khairy
Senior Vice President of Marketing4.9yrsVeri yokVeri yok
Tim Benner
Senior VP of Sales & Senior VP of U.S. Salesless than a yearVeri yokVeri yok
Tara Dunn
Senior VP & GM of LimFlow2.8yrsVeri yokVeri yok
Brian Strauss
Senior Vice President of Engineeringno dataVeri yokVeri yok
Shon Chakrabarti
Chief Medical Officer of LimFlowless than a yearVeri yokVeri yok

2.3yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim: NARI 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Andrew Hykes
CEO, President & Director1.8yrsUS$5.08m0.65%
$ 19.3m
Donald Milder
Independent Chair of the Board13.2yrsUS$266.47k5.27%
$ 156.1m
Jonathan Root
Independent Director13.2yrsUS$230.97k0.92%
$ 27.2m
Dana Mead
Independent Director3.1yrsUS$218.47k0.011%
$ 318.2k
Catherine Szyman
Independent Director5yrsUS$220.51k0.031%
$ 925.3k
William Hoffman
Director9.8yrsUS$198.43k0.93%
$ 27.4m
Cynthia Lucchese
Independent Director5yrsUS$235.93k0.059%
$ 1.7m
Robert Warner
Independent Director2.7yrsUS$220.97k0.012%
$ 351.9k
Rebecca Chambers
Independent Director3.4yrsUS$220.93k0.0095%
$ 280.9k

5.0yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: NARI 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5 yıldır).